aTyr Pharma, Inc. (LIFE)
After hours:
| Previous close | 1.5900 |
| Open | 1.6000 |
| Bid | 1.6100 x 400 |
| Ask | 1.6400 x 400 |
| Day's range | 1.5800 - 1.6400 |
| 52-week range | 1.0800 - 2.7000 |
| Volume | |
| Avg. volume | 558,616 |
| Market cap | 110.064M |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9400 |
| Earnings date | 07 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 22.60 |
GlobeNewswireaTyr Pharma to Participate in April Investor Conferences
SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in two upcoming investor conferences scheduled to take place in April 2024. Details of the conferences appear below: Conference: Evercore ISI Diamonds in the Rough Webinar DayDate: Thursday, April 4, 2024 Time: 10:3
Simply Wall St.aTyr Pharma Full Year 2023 Earnings: Revenues Disappoint
aTyr Pharma ( NASDAQ:LIFE ) Full Year 2023 Results Key Financial Results Net loss: US$50.4m (loss widened by 11% from...
Insider MonkeyaTyr Pharma, Inc. (NASDAQ:LIFE) Q4 2023 Earnings Call Transcript
aTyr Pharma, Inc. (NASDAQ:LIFE) Q4 2023 Earnings Call Transcript March 14, 2024 aTyr Pharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma fourth quarter and full year 2023 conference […]
